These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1387549)

  • 1. N-oleoyl heparin inhibits the amidolytic activity of plasmin and urokinase.
    Legras S; Diczhazi C; Moczar M
    Int J Biol Macromol; 1992 Apr; 14(2):97-9. PubMed ID: 1387549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between heparin and plasmin on amidolysis.
    Kohn S; Sakurama S; Morioka T; Ito Y; Yasukouchi T; Nakagawa S
    Thromb Haemost; 1979 Dec; 42(4):1261-75. PubMed ID: 161669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lipophilic heparin derivative protects elastin against degradation by leucocyte elastase.
    Moczar E; Hornebeck W
    Int J Biol Macromol; 1991 Aug; 13(4):261-2. PubMed ID: 1777434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase.
    Pućkowska A; Midura-Nowaczek K; Bruzgo I
    Acta Pol Pharm; 2008; 65(2):213-5. PubMed ID: 18666427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of plasmin activity by oleic acid.
    Higazi AA; Finci-Yeheskel Z; Samara AA; Aziza R; Mayer M
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):863-6. PubMed ID: 1532491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fibrinolytic enzymes by thrombin inhibitors.
    Gilboa N; Villannueva GB; Fenton JW
    Enzyme; 1988; 40(2-3):144-8. PubMed ID: 2971531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin.
    Baici A; Diczházi C; Neszmélyi A; Móczár E; Hornebeck W
    Biochem Pharmacol; 1993 Nov; 46(9):1545-9. PubMed ID: 8240409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P; Strickland S
    Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced activity of plasmin and plasminogen activation in the presence of oleic acid.
    Higazi AA; Mayer M
    Ann N Y Acad Sci; 1992 Dec; 667():81-3. PubMed ID: 1309074
    [No Abstract]   [Full Text] [Related]  

  • 12. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic studies of urokinase-catalysed hydrolysis of 5-oxo-L-prolylglycyl-L-arginine 4-nitroanilide.
    Ipsen HH; Christensen U
    Biochim Biophys Acta; 1980 Jun; 613(2):476-81. PubMed ID: 6449958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation.
    Sun Z; Zhang PX; Wang P; Gurewich V; Shen HY; Liu JN
    Thromb Res; 2002 Apr; 106(2):105-11. PubMed ID: 12182908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of heparin with human plasmin.
    Bauer PI; Pozsgay M; Machovich R; Elödi P; Horváth I
    Int J Biochem; 1983; 15(6):871-4. PubMed ID: 6222929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of the polyphenols of cider on plasmin and plasminogen activators.
    Ogston D; Lea AG; Langhorne P; Wilson SB
    Br J Haematol; 1985 Aug; 60(4):705-13. PubMed ID: 3161536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of in vitro invasion of human fibrosarcoma cells by a leupeptin analogue inhibiting the urokinase-plasmin system.
    Kawada M; Umezawa K
    Biochem Biophys Res Commun; 1995 Apr; 209(1):25-30. PubMed ID: 7726842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation by heparin of the plasmin-mediated conversion of single-chain to two-chain urokinase-type plasminogen activator.
    Lijnen HR; Collen D
    Thromb Res; 1986 Sep; 43(6):687-90. PubMed ID: 2945283
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro.
    Taitzoglou IA; Tsantarliotou M; Zervos I; Kouretas D; Kokolis NA
    Reproduction; 2001 Jan; 121(1):131-7. PubMed ID: 11226036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
    Walker B; Elmore DT
    Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.